X-139541073-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_000133.4(F9):c.278-3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000936 in 1,068,145 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000133.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- hemophilia BInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia B in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- thrombophilia, X-linked, due to factor 9 defectInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| F9 | NM_000133.4 | c.278-3A>G | splice_region_variant, intron_variant | Intron 3 of 7 | ENST00000218099.7 | NP_000124.1 | ||
| F9 | NM_001313913.2 | c.277+3687A>G | intron_variant | Intron 3 of 6 | NP_001300842.1 | |||
| F9 | XM_005262397.5 | c.278-3A>G | splice_region_variant, intron_variant | Intron 3 of 6 | XP_005262454.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F9 | ENST00000218099.7 | c.278-3A>G | splice_region_variant, intron_variant | Intron 3 of 7 | 1 | NM_000133.4 | ENSP00000218099.2 | |||
| F9 | ENST00000394090.2 | c.277+3687A>G | intron_variant | Intron 3 of 6 | 1 | ENSP00000377650.2 | ||||
| F9 | ENST00000479617.2 | n.242-14A>G | intron_variant | Intron 2 of 3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.36e-7 AC: 1AN: 1068145Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 339217 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor IX deficiency disease Pathogenic:1Other:1
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change falls in intron 3 of the F9 gene. It does not directly change the encoded amino acid sequence of the F9 protein, but it affects a nucleotide within the consensus splice site of the intron. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with hemophilia B (PMID: 28834196, 18624698, 8434583). This variant is also known as IVS3-3A>G and 10389A>G. ClinVar contains an entry for this variant (Variation ID: 92225). Experimental studies have shown that this variant disrupts mRNA splicing and is expected to lead to the loss of protein expression (PMID: 19815722, 28834196).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at